ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 277 filers reported holding ICU MED INC in Q3 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $337,869 | -65.7% | 2,839 | -48.6% | 0.00% | -100.0% |
| Q2 2023 | $983,966 | +0.7% | 5,522 | -6.8% | 0.00% | 0.0% |
| Q1 2023 | $977,388 | +5.5% | 5,925 | +0.7% | 0.00% | 0.0% |
| Q4 2022 | $926,613 | +19.1% | 5,884 | +13.9% | 0.00% | – |
| Q3 2022 | $778,000 | -21.9% | 5,164 | -14.7% | 0.00% | -100.0% |
| Q2 2022 | $996,000 | -85.9% | 6,055 | -80.9% | 0.00% | -66.7% |
| Q1 2022 | $7,072,000 | -58.9% | 31,759 | -56.2% | 0.00% | -62.5% |
| Q4 2021 | $17,225,000 | -13.2% | 72,572 | -14.7% | 0.01% | -11.1% |
| Q3 2021 | $19,845,000 | +12.8% | 85,034 | -0.5% | 0.01% | 0.0% |
| Q2 2021 | $17,596,000 | +18.9% | 85,500 | +18.7% | 0.01% | +12.5% |
| Q1 2021 | $14,799,000 | +973.9% | 72,034 | +1021.5% | 0.01% | +700.0% |
| Q4 2020 | $1,378,000 | +22.1% | 6,423 | +4.0% | 0.00% | 0.0% |
| Q3 2020 | $1,129,000 | -4.6% | 6,176 | -3.7% | 0.00% | 0.0% |
| Q2 2020 | $1,183,000 | -68.2% | 6,414 | -65.2% | 0.00% | -66.7% |
| Q1 2020 | $3,723,000 | +511.3% | 18,453 | +465.7% | 0.00% | – |
| Q4 2019 | $609,000 | -30.1% | 3,262 | -40.3% | 0.00% | -100.0% |
| Q3 2019 | $871,000 | -85.6% | 5,462 | -77.3% | 0.00% | -75.0% |
| Q2 2019 | $6,068,000 | +73.2% | 24,095 | +64.5% | 0.00% | +100.0% |
| Q1 2019 | $3,504,000 | -14.2% | 14,649 | -17.7% | 0.00% | -33.3% |
| Q4 2018 | $4,085,000 | -96.5% | 17,799 | -95.7% | 0.00% | -91.2% |
| Q3 2018 | $115,746,000 | +82.7% | 409,370 | +89.7% | 0.03% | +88.9% |
| Q2 2018 | $63,356,000 | +437.2% | 215,762 | +361.7% | 0.02% | +200.0% |
| Q1 2018 | $11,794,000 | +57.7% | 46,735 | +35.0% | 0.01% | +20.0% |
| Q4 2017 | $7,479,000 | +38.9% | 34,631 | +19.5% | 0.01% | +25.0% |
| Q3 2017 | $5,386,000 | -13.0% | 28,989 | -19.3% | 0.00% | 0.0% |
| Q2 2017 | $6,191,000 | +95.6% | 35,903 | +73.1% | 0.00% | +100.0% |
| Q1 2017 | $3,165,000 | -4.0% | 20,739 | -7.3% | 0.00% | -33.3% |
| Q4 2016 | $3,296,000 | -11.8% | 22,380 | -24.3% | 0.00% | 0.0% |
| Q3 2016 | $3,735,000 | -27.3% | 29,570 | -35.1% | 0.00% | -25.0% |
| Q2 2016 | $5,136,000 | -17.0% | 45,568 | -23.3% | 0.00% | -20.0% |
| Q1 2016 | $6,186,000 | -28.3% | 59,442 | -22.3% | 0.01% | -16.7% |
| Q4 2015 | $8,622,000 | -22.2% | 76,466 | -24.4% | 0.01% | -33.3% |
| Q3 2015 | $11,080,000 | +54.4% | 101,210 | +34.9% | 0.01% | +80.0% |
| Q2 2015 | $7,177,000 | +38.1% | 75,038 | +34.4% | 0.01% | +66.7% |
| Q1 2015 | $5,198,000 | +35.5% | 55,826 | +19.1% | 0.00% | +50.0% |
| Q4 2014 | $3,837,000 | +18.2% | 46,860 | -7.4% | 0.00% | 0.0% |
| Q3 2014 | $3,247,000 | -41.4% | 50,617 | -44.5% | 0.00% | -50.0% |
| Q2 2014 | $5,540,000 | -37.8% | 91,127 | -38.7% | 0.00% | -33.3% |
| Q1 2014 | $8,903,000 | +63.5% | 148,699 | +74.0% | 0.01% | +50.0% |
| Q4 2013 | $5,445,000 | +136.4% | 85,475 | +152.0% | 0.00% | +100.0% |
| Q3 2013 | $2,303,000 | – | 33,920 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |